Lv41
418 积分 2023-02-16 加入
Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non–Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial
2小时前
待确认
Inhaled Sedation in Acute Respiratory Distress Syndrome
2天前
已完结
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial
2天前
已完结
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
2天前
已完结
Neoadjuvant chemotherapy in patients with advanced endometrial cancer
6天前
已完结
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC with PD-L1 Expression ≥50%: 5-Year Outcomes of EMPOWER-Lung 1
8天前
已完结
Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single-Arm Study
8天前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics Evaluation of Ivonescimab, a Novel Bispecific Antibody Targeting PD-1 and VEGF, in Chinese Patients With Advanced Solid Tumors
9天前
已完结
Management of Patients With EGFR Exon 20–Mutant Advanced Non–Small Cell Lung Cancer
11天前
已关闭
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
11天前
已完结
皖公网安备34019202002308
